SODIUM PHOSPHATE

SODIUM PHOSPHATE was reported 10388 times

SODIUM PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 38 0.2923
1 APPENDICOLITH 103 0.2661
2 EOSINOPHIL COUNT NORMAL 3 0.2143
3 SLEEP DISORDER THERAPY 40 0.2020
4 ANALGESIC THERAPY 53 0.1651
5 UREAPLASMA TEST POSITIVE 2 0.1538
6 DRUG THERAPY 51 0.1504
7 ANTICOAGULANT THERAPY 38 0.1338
8 POST STROKE DEPRESSION 3 0.0789
9 CONGENITAL HIATUS HERNIA 16 0.0702
10 BACTEROIDES INFECTION 17 0.0651
11 COLONIC PSEUDO-OBSTRUCTION 17 0.0609
12 MALIGNANT MELANOMA STAGE 0 12 0.0574
13 ACUTE PHOSPHATE NEPHROPATHY 7 0.0449
14 DIPHTHERIA 2 0.0426
15 HYPERPHOSPHATAEMIA 74 0.0344
16 NON-PITTING OEDEMA 3 0.0341
17 BURKHOLDERIA TEST POSITIVE 4 0.0323
18 LOSS OF BLADDER SENSATION 5 0.0307
19 MECONIUM ILEUS 2 0.0303
20 BLOOD PHOSPHORUS INCREASED 80 0.0293
21 TOTAL LUNG CAPACITY DECREASED 30 0.0188
22 MUSCLE OEDEMA 4 0.0185
23 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 16 0.0173
24 HYPOGONADISM 17 0.0168
25 OESOPHAGEAL NEOPLASM 3 0.0162
26 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 2 0.0161
27 RED BLOOD CELLS URINE POSITIVE 15 0.0155
28 ANTICIPATORY ANXIETY 4 0.0147
29 INCISION SITE PAIN 17 0.0145
30 URINARY STRAINING 2 0.0144
31 BLOOD URIC ACID INCREASED 77 0.0133
32 AORTIC STENOSIS 46 0.0132
33 IRON DEFICIENCY 56 0.0124
34 TONGUE FUNGAL INFECTION 2 0.0116
35 HYPOPHOSPHATAEMIA 85 0.0115
36 APLASTIC ANAEMIA 60 0.0115
37 HERPES ZOSTER REACTIVATION 3 0.0115
38 APPENDICITIS 105 0.0112
39 LUNG OPACITY 29 0.0110
40 SICCA SYNDROME 2 0.0104
41 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 2 0.0101
42 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 51 0.0101
43 MYASTHENIA GRAVIS 73 0.0090
44 VENTRICULAR FIBRILLATION 95 0.0085
45 NEPHROCALCINOSIS 10 0.0084
46 MUTISM 12 0.0083
47 NECROTISING OESOPHAGITIS 4 0.0080
48 FOOD REFUSAL 7 0.0080
49 CARDIOGENIC SHOCK 111 0.0077
50 HYPOPHOSPHATAEMIC OSTEOMALACIA 2 0.0076
51 INCISION SITE IMPAIRED HEALING 3 0.0074
52 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 1 0.0074
53 SPINAL DECOMPRESSION 3 0.0071
54 DELAYED GRAFT FUNCTION 5 0.0070
55 INTESTINAL PSEUDO-OBSTRUCTION 6 0.0068
56 CATHETER SITE CELLULITIS 2 0.0068
57 OTITIS MEDIA ACUTE 5 0.0068
58 BILIARY SEPSIS 3 0.0065
59 BREAST CELLULITIS 2 0.0063
60 RETROPERITONEAL ABSCESS 2 0.0063
61 HYPERCALCIURIA 3 0.0061
62 CLOSTRIDIUM TEST POSITIVE 13 0.0059
63 DERMATITIS DIAPER 4 0.0057
64 SCROTAL PAIN 3 0.0056
65 PRODUCT COMPOUNDING QUALITY ISSUE 2 0.0055
66 TROPONIN INCREASED 41 0.0054
67 BLOOD CALCIUM INCREASED 47 0.0054
68 CAPILLARY DISORDER 2 0.0052
69 ACINETOBACTER TEST POSITIVE 1 0.0052
70 LUNG CYST 2 0.0051
71 PLEURITIC PAIN 13 0.0047
72 HYPERCHLORAEMIA 3 0.0047
73 ENTEROCUTANEOUS FISTULA 4 0.0045
74 BLOOD PHOSPHORUS ABNORMAL 2 0.0042
75 BACTERIAL INFECTION 79 0.0042
76 SKIN TEXTURE ABNORMAL 4 0.0042
77 HYPERLIPIDAEMIA 49 0.0041
78 IMPETIGO 6 0.0040
79 RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0040
80 FANCONI SYNDROME ACQUIRED 7 0.0040
81 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 6 0.0039
82 ASCITES 115 0.0039
83 CAUDA EQUINA SYNDROME 3 0.0039
84 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 67 0.0039
85 RESPIRATORY SYMPTOM 11 0.0039
86 BILIRUBIN CONJUGATED INCREASED 9 0.0038
87 MULTIPLE ORGAN DYSFUNCTION SYNDROME 109 0.0038
88 ABDOMINAL WALL HAEMORRHAGE 1 0.0038
89 SKIN CANDIDA 2 0.0038
90 BLOOD FIBRINOGEN INCREASED 3 0.0038
91 GOUTY ARTHRITIS 3 0.0038
92 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
93 BACTERIURIA 2 0.0035
94 RENAL TUBULAR DYSFUNCTION 2 0.0035
95 BLOOD FIBRINOGEN DECREASED 4 0.0035
96 HAEMATOMA INFECTION 2 0.0035
97 BLOOD TEST ABNORMAL 45 0.0032
98 END STAGE RENAL DISEASE 58 0.0032
99 HYPERAESTHESIA TEETH 4 0.0032
100 BLADDER CATHETERISATION 3 0.0031
101 ENTEROCOCCUS TEST POSITIVE 2 0.0031
102 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 2 0.0030
103 LYMPHOCELE 2 0.0030
104 BLOOD PHOSPHORUS DECREASED 11 0.0030
105 PROTEIN URINE PRESENT 15 0.0030
106 SUBSTANCE DEPENDENCE 2 0.0030
107 BRAIN STEM INFARCTION 3 0.0029
108 CYTOKINE STORM 2 0.0029
109 ISCHAEMIC HEPATITIS 4 0.0029
110 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
111 BLAST CELL COUNT INCREASED 3 0.0029
112 CYTOKINE RELEASE SYNDROME 57 0.0028
113 BREATH SOUNDS ABNORMAL 14 0.0028
114 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
115 BACTERIAL DISEASE CARRIER 2 0.0027
116 AORTIC VALVE SCLEROSIS 2 0.0027
117 NOSOCOMIAL INFECTION 6 0.0027
118 NEURALGIA 66 0.0027
119 VITAMIN B COMPLEX DEFICIENCY 2 0.0027
120 MULTIPLE DRUG THERAPY 2 0.0027
121 GOUT 47 0.0026
122 LYMPHOCYTE COUNT DECREASED 46 0.0026
123 PANCREATIC PSEUDOCYST 2 0.0026
124 ULCER 41 0.0026
125 HYPORESPONSIVE TO STIMULI 3 0.0026
126 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
127 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
128 BILE DUCT STENOSIS 3 0.0025
129 BRONCHOPULMONARY DYSPLASIA 2 0.0025
130 ENTEROCOCCAL SEPSIS 2 0.0025
131 INCISION SITE HAEMORRHAGE 2 0.0025
132 SPUTUM CULTURE POSITIVE 2 0.0025
133 INFANTILE APNOEA 2 0.0025
134 BALANOPOSTHITIS 2 0.0024
135 BLOOD UREA DECREASED 3 0.0024
136 HYPERNATRAEMIA 12 0.0024
137 MICROCYTIC ANAEMIA 5 0.0024
138 NECROTISING COLITIS 3 0.0024
139 PROCEDURAL HYPOTENSION 2 0.0024
140 NEUTROPHIL COUNT INCREASED 24 0.0023
141 RECALLED PRODUCT 4 0.0023
142 ABDOMINAL SEPSIS 2 0.0023
143 IMPLANTABLE DEFIBRILLATOR INSERTION 3 0.0023
144 BLOOD ALBUMIN INCREASED 2 0.0022
145 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
146 CANDIDA SEPSIS 2 0.0022
147 ANAEMIA OF CHRONIC DISEASE 2 0.0022
148 TUMOUR LYSIS SYNDROME 19 0.0022
149 HYPONATRAEMIA 121 0.0021
150 KLEBSIELLA BACTERAEMIA 2 0.0021
151 ADRENAL DISORDER 4 0.0021
152 LYMPHADENITIS 5 0.0021
153 HYPOTHALAMO-PITUITARY DISORDER 3 0.0021
154 NORMOCYTIC ANAEMIA 3 0.0020
155 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 12 0.0020
156 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
157 ASPIRATION 22 0.0020
158 DEVICE RELATED SEPSIS 4 0.0020
159 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
160 RENAL FAILURE CHRONIC 15 0.0019
161 HEPATOSPLENOMEGALY 5 0.0019
162 OSTEOMALACIA 3 0.0019
163 BLOOD UREA INCREASED 32 0.0019
164 FUNGAEMIA 3 0.0019
165 URETEROLITHIASIS 2 0.0019
166 ENTEROCOCCAL BACTERAEMIA 2 0.0019
167 HYDROCELE 2 0.0019
168 CEREBRAL ARTERY OCCLUSION 2 0.0019
169 CLAUSTROPHOBIA 2 0.0018
170 CHOLECYSTITIS INFECTIVE 5 0.0018
171 ANTIPSYCHOTIC DRUG LEVEL INCREASED 5 0.0018
172 LEUKAEMIA RECURRENT 3 0.0018
173 BLOOD ALBUMIN DECREASED 14 0.0018
174 DIFFUSE ALVEOLAR DAMAGE 2 0.0017
175 CARBON DIOXIDE DECREASED 2 0.0017
176 NEPHROGENIC ANAEMIA 8 0.0017
177 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 4 0.0017
178 BLOOD CHOLESTEROL INCREASED 80 0.0017
179 MUCOSAL INFLAMMATION 44 0.0017
180 BRONCHIAL HYPERREACTIVITY 2 0.0017
181 DIABETES INSIPIDUS 4 0.0017
182 MONOCYTE COUNT DECREASED 2 0.0016
183 CALCIPHYLAXIS 3 0.0016
184 ENCEPHALOPATHY 40 0.0016
185 IRON DEFICIENCY ANAEMIA 15 0.0016
186 PNEUMOPERITONEUM 3 0.0016
187 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
188 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
189 HYPERPARATHYROIDISM SECONDARY 4 0.0016
190 BLOOD CREATININE DECREASED 5 0.0016
191 MECHANICAL VENTILATION 3 0.0016
192 GASTRIC ULCER PERFORATION 2 0.0016
193 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
194 BACTERIAL SEPSIS 5 0.0015
195 GENERALISED OEDEMA 19 0.0015
196 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
197 ANION GAP INCREASED 2 0.0015
198 FEBRILE NEUTROPENIA 98 0.0015
199 HYPERPARATHYROIDISM 3 0.0015
200 BILIARY TRACT DISORDER 2 0.0014
201 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
202 PERITONEAL HAEMORRHAGE 2 0.0014
203 BODY TEMPERATURE FLUCTUATION 3 0.0014
204 SEPSIS 159 0.0014
205 FULL BLOOD COUNT ABNORMAL 15 0.0014
206 FANCONI SYNDROME 2 0.0014
207 RALES 8 0.0014
208 MONOCYTE COUNT INCREASED 5 0.0014
209 BILIARY DILATATION 2 0.0014
210 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 71 0.0014
211 LIVER FUNCTION TEST INCREASED 29 0.0013
212 CHOLESTATIC LIVER INJURY 3 0.0013
213 HYPERCHOLESTEROLAEMIA 13 0.0013
214 BACTERIAL TEST POSITIVE 3 0.0013
215 METABOLIC ENCEPHALOPATHY 4 0.0013
216 HYPOXIA 46 0.0013
217 BREAKTHROUGH PAIN 3 0.0013
218 BLOOD CREATININE INCREASED 84 0.0013
219 HYPOALBUMINAEMIA 10 0.0013
220 RHINOVIRUS INFECTION 5 0.0013
221 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
222 OESOPHAGEAL PAIN 5 0.0013
223 INCORRECT DOSE ADMINISTERED BY PRODUCT 2 0.0012
224 ABDOMINAL DISTENSION 130 0.0012
225 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
226 MICTURITION URGENCY 14 0.0012
227 GASTROINTESTINAL SOUNDS ABNORMAL 6 0.0012
228 NEUROTOXICITY 21 0.0012
229 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
230 ECCHYMOSIS 8 0.0012
231 PUPIL FIXED 2 0.0012
232 PSEUDOMONAL SEPSIS 2 0.0011
233 ATELECTASIS 11 0.0011
234 SERUM FERRITIN INCREASED 6 0.0011
235 EMBOLIC STROKE 4 0.0011
236 MITRAL VALVE DISEASE 2 0.0011
237 LUNG TRANSPLANT 4 0.0011
238 GENERAL PHYSICAL HEALTH DETERIORATION 130 0.0011
239 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
240 VOCAL CORD PARALYSIS 2 0.0011
241 HYPOCALCAEMIA 21 0.0011
242 SUSPECTED OFF LABEL USE 5 0.0011
243 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
244 STOMA SITE DISCHARGE 3 0.0011
245 AMYLASE INCREASED 4 0.0011
246 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
247 LUNG CONSOLIDATION 3 0.0011
248 DEFORMITY 10 0.0011
249 BLADDER SPASM 2 0.0011
250 ORAL CANDIDIASIS 14 0.0011
251 CHOLECYSTITIS ACUTE 6 0.0011
252 PNEUMATOSIS INTESTINALIS 3 0.0011
253 ACIDOSIS 8 0.0010
254 HYPOREFLEXIA 2 0.0010
255 BRONCHIECTASIS 7 0.0010
256 DELIRIUM 36 0.0010
257 TRANSAMINASES INCREASED 23 0.0010
258 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
259 ELECTROLYTE IMBALANCE 12 0.0010
260 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
261 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
262 DRY MOUTH 83 0.0010
263 PULMONARY HAEMORRHAGE 8 0.0010
264 COLOSTOMY 2 0.0010
265 HYPERVOLAEMIA 5 0.0010
266 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
267 DIABETES MELLITUS 76 0.0010
268 SLEEP DISORDER 70 0.0010
269 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
270 PANCREATITIS ACUTE 22 0.0010
271 DUODENITIS 3 0.0010
272 CHOLANGITIS 6 0.0010
273 NEUTROPENIC COLITIS 2 0.0010
274 EOSINOPHILIC PNEUMONIA 3 0.0010
275 URINARY BLADDER HAEMORRHAGE 2 0.0009
276 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
277 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
278 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
279 PLEURAL EFFUSION 57 0.0009
280 BACTERAEMIA 11 0.0009
281 DIABETIC NEPHROPATHY 2 0.0009
282 INTESTINAL ISCHAEMIA 5 0.0009
283 ASPARTATE AMINOTRANSFERASE INCREASED 48 0.0009
284 PROSTATE CANCER METASTATIC 3 0.0009
285 LARGE INTESTINAL OBSTRUCTION 2 0.0009
286 BK VIRUS INFECTION 3 0.0009
287 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
288 LOWER RESPIRATORY TRACT INFECTION 40 0.0009
289 WOUND COMPLICATION 3 0.0009
290 THROMBOSIS 70 0.0009
291 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
292 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
293 OVARIAN HYPERSTIMULATION SYNDROME 2 0.0009
294 RIGHT VENTRICULAR FAILURE 6 0.0009
295 ANAEMIA 162 0.0008
296 ACUTE LUNG INJURY 1 0.0008
297 HAND DEFORMITY 11 0.0008
298 ODYNOPHAGIA 5 0.0008
299 LACUNAR INFARCTION 2 0.0008
300 KIDNEY TRANSPLANT REJECTION 4 0.0008
301 RENAL TRANSPLANT 3 0.0008
302 PULMONARY EMBOLISM 78 0.0008
303 SCIATICA 13 0.0008
304 RETROPERITONEAL HAEMORRHAGE 2 0.0008
305 STAPHYLOCOCCAL SEPSIS 4 0.0008
306 HYPERCALCAEMIA 10 0.0008
307 TACHYPNOEA 11 0.0008
308 SUFFOCATION FEELING 2 0.0008
309 INFREQUENT BOWEL MOVEMENTS 2 0.0008
310 URINE OUTPUT DECREASED 7 0.0008
311 STEM CELL TRANSPLANT 2 0.0008
312 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
313 PROTEIN TOTAL DECREASED 3 0.0008
314 PLATELET DISORDER 2 0.0008
315 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
316 FACE INJURY 3 0.0008
317 HYPOMAGNESAEMIA 11 0.0008
318 ABDOMINAL INFECTION 2 0.0008
319 HYPOKALAEMIA 36 0.0008
320 ACUTE RESPIRATORY FAILURE 15 0.0008
321 BLOOD CHLORIDE DECREASED 2 0.0008
322 HYPERBILIRUBINAEMIA 8 0.0008
323 LIPOMA 2 0.0008
324 VENTRICULAR DYSFUNCTION 2 0.0008
325 FAILURE TO THRIVE 4 0.0008
326 EPIGASTRIC DISCOMFORT 3 0.0008
327 URINE OUTPUT INCREASED 2 0.0008
328 WALKING AID USER 5 0.0008
329 CONSTIPATION 165 0.0008
330 DRUG INTOLERANCE 73 0.0008
331 URINARY RETENTION 25 0.0007
332 OVERWEIGHT 4 0.0007
333 C-REACTIVE PROTEIN INCREASED 27 0.0007
334 PRODUCT RESIDUE PRESENT 4 0.0007
335 SPUTUM DISCOLOURED 7 0.0007
336 ABDOMINAL RIGIDITY 2 0.0007
337 SEPTIC SHOCK 32 0.0007
338 PERIPHERAL ISCHAEMIA 3 0.0007
339 SUBDURAL HAEMORRHAGE 2 0.0007
340 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
341 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
342 RASH MORBILLIFORM 2 0.0007
343 INTENTIONAL PRODUCT MISUSE 63 0.0007
344 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
345 LEUKOCYTOSIS 13 0.0007
346 INTESTINAL OBSTRUCTION 27 0.0007
347 SWELLING 67 0.0007
348 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
349 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
350 PURULENT DISCHARGE 3 0.0007
351 PSEUDOMONAS INFECTION 6 0.0007
352 EXERCISE TOLERANCE DECREASED 4 0.0007
353 ENTEROCOLITIS 4 0.0007
354 HYPOKINESIA 10 0.0007
355 DIVERTICULUM INTESTINAL 3 0.0007
356 HYPERTRIGLYCERIDAEMIA 4 0.0007
357 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
358 BLOOD CREATINE INCREASED 3 0.0007
359 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
360 BRAIN HERNIATION 2 0.0007
361 URINE ANALYSIS ABNORMAL 2 0.0007
362 HYDRONEPHROSIS 5 0.0007
363 MIXED LIVER INJURY 2 0.0007
364 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
365 VASCULAR DEVICE INFECTION 3 0.0007
366 PNEUMONITIS 18 0.0007
367 JOINT INJURY 14 0.0007
368 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
369 INTRACARDIAC THROMBUS 2 0.0007
370 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
371 LOCALISED OEDEMA 3 0.0006
372 DIASTOLIC DYSFUNCTION 2 0.0006
373 DIARRHOEA HAEMORRHAGIC 6 0.0006
374 ABDOMINAL PAIN 149 0.0006
375 SKIN TIGHTNESS 3 0.0006
376 SINUS TACHYCARDIA 9 0.0006
377 PNEUMONIA VIRAL 2 0.0006
378 MALNUTRITION 7 0.0006
379 CUSHINGOID 2 0.0006
380 VENTRICULAR HYPOKINESIA 2 0.0006
381 BLOOD CALCIUM DECREASED 7 0.0006
382 ENTEROCOCCAL INFECTION 3 0.0006
383 STATUS EPILEPTICUS 7 0.0006
384 ACUTE LEUKAEMIA 1 0.0006
385 GASTROENTERITIS 9 0.0006
386 LIVER ABSCESS 2 0.0006
387 RENAL TUBULAR NECROSIS 6 0.0006
388 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
389 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
390 OTITIS MEDIA 2 0.0006
391 EMBOLISM 5 0.0006
392 PNEUMONIA ASPIRATION 15 0.0006
393 VEIN DISORDER 3 0.0006
394 NEPHRITIS 2 0.0006
395 SPLENOMEGALY 7 0.0006
396 HYPOTHYROIDISM 19 0.0006
397 KLEBSIELLA INFECTION 3 0.0006
398 COVID-19 PNEUMONIA 7 0.0006
399 PATHOLOGICAL FRACTURE 3 0.0006
400 ATAXIA 7 0.0006
401 IMPAIRED GASTRIC EMPTYING 8 0.0006
402 ACUTE HEPATIC FAILURE 8 0.0006
403 REGURGITATION 2 0.0006
404 TRISMUS 3 0.0006
405 BLOOD MAGNESIUM DECREASED 5 0.0006
406 PULMONARY FIBROSIS 11 0.0006
407 BRONCHIOLITIS 2 0.0006
408 SUDDEN DEATH 6 0.0006
409 DUODENAL ULCER 4 0.0006
410 NEUTROPHIL COUNT DECREASED 23 0.0006
411 PHARYNGITIS 7 0.0006
412 FIBRIN D DIMER INCREASED 2 0.0006
413 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
414 GRAFT VERSUS HOST DISEASE 4 0.0006
415 ALANINE AMINOTRANSFERASE INCREASED 34 0.0006
416 MOUTH HAEMORRHAGE 4 0.0005
417 VENTRICULAR TACHYCARDIA 9 0.0005
418 RESPIRATORY DISTRESS 15 0.0005
419 UROSEPSIS 5 0.0005
420 HIATUS HERNIA 7 0.0005
421 INTRACRANIAL PRESSURE INCREASED 3 0.0005
422 PULMONARY MASS 8 0.0005
423 ACUTE KIDNEY INJURY 82 0.0005
424 INTESTINAL PERFORATION 6 0.0005
425 AUTOIMMUNE THYROIDITIS 2 0.0005
426 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
427 PERONEAL NERVE PALSY 3 0.0005
428 MUSCULOSKELETAL STIFFNESS 46 0.0005
429 HAEMODYNAMIC INSTABILITY 4 0.0005
430 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
431 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
432 RESPIRATORY FAILURE 38 0.0005
433 SINUS BRADYCARDIA 5 0.0005
434 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
435 APHTHOUS ULCER 4 0.0005
436 FAECES HARD 2 0.0005
437 VITAMIN D DEFICIENCY 5 0.0005
438 PROSTATOMEGALY 2 0.0005
439 SOMNOLENCE 102 0.0005
440 CEREBRAL ATROPHY 2 0.0005
441 AZOTAEMIA 2 0.0005
442 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
443 HEPATIC FAILURE 15 0.0005
444 VITAMIN B12 DEFICIENCY 2 0.0005
445 POLYURIA 4 0.0005
446 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
447 CHOLELITHIASIS 16 0.0005
448 SMALL INTESTINAL OBSTRUCTION 6 0.0005
449 ARTHRITIS BACTERIAL 2 0.0005
450 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
451 BLOOD SODIUM DECREASED 9 0.0005
452 TRANSFUSION 5 0.0005
453 HAEMODIALYSIS 4 0.0005
454 HALLUCINATIONS, MIXED 2 0.0005
455 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
456 BLOOD URINE PRESENT 9 0.0005
457 RENAL FAILURE ACUTE 20 0.0005
458 AORTIC VALVE INCOMPETENCE 2 0.0005
459 HAEMOGLOBIN DECREASED 48 0.0005
460 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
461 CONDITION AGGRAVATED 142 0.0005
462 PROCTALGIA 3 0.0005
463 PANCYTOPENIA 26 0.0005
464 ABSCESS INTESTINAL 1 0.0005
465 CORONARY ARTERY DISEASE 14 0.0005
466 CARDIAC MURMUR 4 0.0005
467 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
468 IMMOBILE 2 0.0005
469 HYPERKALAEMIA 16 0.0005
470 HAEMATOCRIT DECREASED 9 0.0005
471 OEDEMA PERIPHERAL 55 0.0005
472 RESPIRATORY RATE INCREASED 4 0.0005
473 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
474 MENINGITIS 3 0.0004
475 THROMBOCYTOPENIA 50 0.0004
476 URINARY TRACT DISORDER 2 0.0004
477 MITRAL VALVE INCOMPETENCE 5 0.0004
478 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
479 HAEMATURIA 15 0.0004
480 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
481 CARDIOVASCULAR DISORDER 11 0.0004
482 PROCEDURAL PAIN 12 0.0004
483 MENTAL STATUS CHANGES 12 0.0004
484 PULMONARY HYPERTENSION 9 0.0004
485 HAEMOPTYSIS 12 0.0004
486 FLANK PAIN 4 0.0004
487 UNRESPONSIVE TO STIMULI 11 0.0004
488 CARDIAC TAMPONADE 2 0.0004
489 PRODUCT SUPPLY ISSUE 3 0.0004
490 NEUTROPENIC SEPSIS 3 0.0004
491 CHOLECYSTITIS 5 0.0004
492 SUBDURAL HAEMATOMA 6 0.0004
493 GUILLAIN-BARRE SYNDROME 2 0.0004
494 DYSTONIA 8 0.0004
495 FLUID OVERLOAD 6 0.0004
496 THROMBOTIC MICROANGIOPATHY 4 0.0004
497 BLOOD BILIRUBIN INCREASED 11 0.0004
498 THERAPY CHANGE 4 0.0004
499 PANCREATIC DISORDER 2 0.0004
500 ACUTE PSYCHOSIS 1 0.0004
501 SMALL FOR DATES BABY 2 0.0004
502 HAEMORRHAGE INTRACRANIAL 6 0.0004
503 CARDIAC ARREST 33 0.0004
504 BRAIN OEDEMA 5 0.0004
505 TOXIC ENCEPHALOPATHY 2 0.0004
506 DYSLIPIDAEMIA 2 0.0004
507 SHOCK 9 0.0004
508 DEVICE RELATED INFECTION 6 0.0004
509 INCREASED UPPER AIRWAY SECRETION 2 0.0004
510 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
511 PERICARDIAL EFFUSION 9 0.0004
512 VOMITING 183 0.0004
513 LYMPHOMA 6 0.0004
514 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
515 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
516 POOR VENOUS ACCESS 4 0.0004
517 MALABSORPTION 2 0.0004
518 FOLLICULITIS 4 0.0004
519 BLOOD LACTIC ACID INCREASED 2 0.0004
520 PULMONARY CONGESTION 5 0.0004
521 PNEUMOTHORAX 6 0.0004
522 RENAL CYST 3 0.0004
523 TRICUSPID VALVE INCOMPETENCE 3 0.0004
524 PREMATURE DELIVERY 6 0.0004
525 METABOLIC ACIDOSIS 12 0.0004
526 INTESTINAL RESECTION 2 0.0004
527 DYSPNOEA EXERTIONAL 14 0.0004
528 ANAL ABSCESS 2 0.0004
529 STRESS FRACTURE 2 0.0004
530 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
531 OESOPHAGITIS 4 0.0004
532 NONSPECIFIC REACTION 2 0.0004
533 PYREXIA 126 0.0004
534 GASTROINTESTINAL PAIN 4 0.0004
535 CYTOMEGALOVIRUS INFECTION 6 0.0004
536 LEUKOPENIA 18 0.0004
537 STEVENS-JOHNSON SYNDROME 8 0.0004
538 STREPTOCOCCAL INFECTION 2 0.0004
539 PLATELET COUNT DECREASED 38 0.0004
540 OCULAR DISCOMFORT 4 0.0004
541 CANDIDA INFECTION 6 0.0004
542 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
543 GRANULOCYTOPENIA 2 0.0004
544 DERMATITIS CONTACT 4 0.0004
545 BRONCHOSPASM 5 0.0004
546 HYPERTONIA 2 0.0003
547 PYELONEPHRITIS 3 0.0003
548 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
549 HYPOVOLAEMIA 2 0.0003
550 SPINAL OSTEOARTHRITIS 3 0.0003
551 RIB FRACTURE 7 0.0003
552 LUNG INFILTRATION 3 0.0003
553 LIVER DISORDER 15 0.0003
554 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
555 PULMONARY OEDEMA 15 0.0003
556 HAEMOLYTIC ANAEMIA 3 0.0003
557 PROTHROMBIN TIME PROLONGED 2 0.0003
558 MYOSITIS 3 0.0003
559 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
560 ANAL INCONTINENCE 3 0.0003
561 HEPATITIS B 2 0.0003
562 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
563 INGUINAL HERNIA 2 0.0003
564 PNEUMONIA BACTERIAL 3 0.0003
565 GRAND MAL CONVULSION 3 0.0003
566 PNEUMONIA 105 0.0003
567 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
568 FAECES DISCOLOURED 7 0.0003
569 NEPHROPATHY 3 0.0003
570 NERVOUS SYSTEM DISORDER 10 0.0003
571 POISONING 4 0.0003
572 PAIN IN JAW 9 0.0003
573 RECALLED PRODUCT ADMINISTERED 3 0.0003
574 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
575 ABSCESS 5 0.0003
576 HYPOPHAGIA 8 0.0003
577 HEPATITIS 8 0.0003
578 ENTERITIS 2 0.0003
579 POST PROCEDURAL COMPLICATION 6 0.0003
580 ANGINA UNSTABLE 2 0.0003
581 NODULE 4 0.0003
582 NEPHROLITHIASIS 14 0.0003
583 HYPOGAMMAGLOBULINAEMIA 2 0.0003
584 CORONAVIRUS INFECTION 2 0.0003
585 CARDIAC FAILURE ACUTE 2 0.0003
586 COAGULOPATHY 5 0.0003
587 BLOOD POTASSIUM DECREASED 9 0.0003
588 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
589 POST-TRAUMATIC STRESS DISORDER 2 0.0003
590 COLITIS ISCHAEMIC 2 0.0003
591 FEEDING DISORDER 6 0.0003
592 DRUG LEVEL DECREASED 3 0.0003
593 DIABETIC KETOACIDOSIS 7 0.0003
594 PERITONITIS 6 0.0003
595 ENCEPHALITIS 2 0.0003
596 EYE DISCHARGE 3 0.0003
597 HYPERTRANSAMINASAEMIA 2 0.0003
598 OXYGEN SATURATION DECREASED 16 0.0003
599 INCONTINENCE 3 0.0003
600 RENAL PAIN 3 0.0003
601 DIALYSIS 4 0.0003
602 METASTASIS 2 0.0003
603 RED BLOOD CELL COUNT DECREASED 8 0.0003
604 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
605 MOBILITY DECREASED 20 0.0003
606 LACTIC ACIDOSIS 9 0.0003
607 CHRONIC KIDNEY DISEASE 21 0.0003
608 LIVER FUNCTION TEST ABNORMAL 8 0.0003
609 FAECES SOFT 2 0.0003
610 HYPERTENSION 58 0.0003
611 ORAL DISORDER 2 0.0003
612 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
613 URINARY INCONTINENCE 8 0.0003
614 COLITIS 10 0.0003
615 RENAL FAILURE 35 0.0003
616 LIPASE INCREASED 2 0.0003
617 SEROTONIN SYNDROME 5 0.0003
618 POST PROCEDURAL HAEMORRHAGE 3 0.0003
619 LUNG INFECTION 4 0.0003
620 EJECTION FRACTION DECREASED 4 0.0003
621 COGNITIVE DISORDER 12 0.0003
622 ATRIAL FIBRILLATION 25 0.0003
623 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
624 MUSCLE RIGIDITY 3 0.0003
625 NEUTROPENIA 34 0.0002
626 TRANSPLANT REJECTION 2 0.0002
627 BLOOD DISORDER 2 0.0002
628 DYSPNOEA 141 0.0002
629 NAUSEA 195 0.0002
630 URINARY TRACT INFECTION 42 0.0002
631 BONE MARROW FAILURE 5 0.0002
632 CEREBRAL INFARCTION 6 0.0002
633 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
634 LUNG DISORDER 12 0.0002
635 DYSURIA 9 0.0002
636 ABNORMAL FAECES 2 0.0002
637 STAPHYLOCOCCAL INFECTION 8 0.0002
638 SPINAL COMPRESSION FRACTURE 2 0.0002
639 ILEUS 3 0.0002
640 HEPATIC FUNCTION ABNORMAL 9 0.0002
641 EOSINOPHIL COUNT INCREASED 2 0.0002
642 HYPOTENSION 48 0.0002
643 RENAL IMPAIRMENT 20 0.0002
644 FACIAL PARALYSIS 2 0.0002
645 RESPIRATORY DISORDER 7 0.0002
646 PSYCHOLOGICAL TRAUMA 2 0.0002
647 HAEMATOMA 6 0.0002
648 MYOPATHY 2 0.0002
649 STOMATITIS 14 0.0002
650 AMENORRHOEA 4 0.0002
651 SARS-COV-2 TEST POSITIVE 3 0.0002
652 ABDOMINAL ABSCESS 1 0.0002
653 LETHARGY 13 0.0002
654 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
655 EAR INFECTION 6 0.0002
656 TACHYCARDIA 20 0.0002
657 DEHYDRATION 30 0.0002
658 EYE HAEMORRHAGE 3 0.0002
659 OROPHARYNGEAL DISCOMFORT 2 0.0002
660 DYSPHAGIA 21 0.0002
661 HYPERGLYCAEMIA 8 0.0002
662 CELLULITIS 11 0.0002
663 RESPIRATORY ARREST 6 0.0002
664 HIP FRACTURE 7 0.0002
665 ANAPHYLACTIC REACTION 12 0.0002
666 OFF LABEL USE 188 0.0002
667 MASS 3 0.0002
668 RENAL DISORDER 10 0.0002
669 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
670 LACERATION 2 0.0002
671 ARTERIOSCLEROSIS 2 0.0002
672 GASTROINTESTINAL DISORDER 19 0.0002
673 GASTRIC ULCER 4 0.0002
674 PROTEINURIA 4 0.0002
675 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
676 DEPRESSED MOOD 11 0.0002
677 TOXICITY TO VARIOUS AGENTS 35 0.0002
678 ERUCTATION 4 0.0002
679 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
680 HEPATOMEGALY 2 0.0002
681 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
682 OEDEMA 11 0.0002
683 ABDOMINAL TENDERNESS 1 0.0002
684 NEOPLASM PROGRESSION 7 0.0002
685 BRAIN INJURY 2 0.0002
686 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
687 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
688 PERITONITIS BACTERIAL 2 0.0002
689 OSTEOPENIA 3 0.0002
690 HAEMATEMESIS 5 0.0002
691 SUBARACHNOID HAEMORRHAGE 2 0.0002
692 VENTRICULAR EXTRASYSTOLES 2 0.0002
693 TENDERNESS 2 0.0002
694 RESTLESSNESS 7 0.0002
695 MUSCULOSKELETAL PAIN 10 0.0002
696 SEIZURE 22 0.0002
697 ARRHYTHMIA 9 0.0002
698 GASTRITIS 5 0.0002
699 MOUTH ULCERATION 4 0.0002
700 OBESITY 3 0.0002
701 EATING DISORDER 4 0.0002
702 CHILLS 22 0.0002
703 CARDIAC FAILURE CONGESTIVE 15 0.0002
704 JAUNDICE 5 0.0002
705 DECREASED ACTIVITY 2 0.0002
706 BLOOD POTASSIUM INCREASED 3 0.0002
707 PALLOR 5 0.0002
708 PRODUCT USE IN UNAPPROVED INDICATION 45 0.0002
709 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
710 DRUG LEVEL INCREASED 3 0.0002
711 BLOOD GLUCOSE INCREASED 34 0.0002
712 ORAL PAIN 4 0.0002
713 SKIN INFECTION 2 0.0002
714 NEPHROPATHY TOXIC 2 0.0002
715 ABNORMAL BEHAVIOUR 7 0.0002
716 DIARRHOEA 114 0.0002
717 MYOCARDIAL ISCHAEMIA 2 0.0002
718 CARDIAC FAILURE 14 0.0002
719 MUSCULOSKELETAL DISCOMFORT 3 0.0002
720 GASTRIC HAEMORRHAGE 2 0.0002
721 MULTI-ORGAN FAILURE 3 0.0002
722 EOSINOPHILIA 3 0.0002
723 PANCREATITIS 9 0.0002
724 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
725 WHEEZING 10 0.0002
726 BLOOD IRON DECREASED 2 0.0002
727 ASTHMA 19 0.0002
728 CEREBRAL HAEMORRHAGE 6 0.0002
729 BLOOD PRESSURE FLUCTUATION 4 0.0002
730 APHASIA 5 0.0002
731 ABDOMINAL PAIN UPPER 34 0.0002
732 ASTHENIA 62 0.0002
733 ADRENAL INSUFFICIENCY 2 0.0002
734 NOCTURIA 2 0.0002
735 BONE DISORDER 3 0.0002
736 MUSCLE SPASTICITY 2 0.0002
737 TREMOR 27 0.0002
738 CONJUNCTIVITIS 3 0.0002
739 LIMB DISCOMFORT 5 0.0002
740 AGRANULOCYTOSIS 3 0.0002
741 HEPATIC STEATOSIS 3 0.0002
742 INJECTION SITE REACTION 11 0.0002
743 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
744 NEUROPATHY PERIPHERAL 15 0.0002
745 CHOLESTASIS 3 0.0002
746 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
747 INFUSION SITE PAIN 2 0.0002
748 RASH GENERALISED 4 0.0002
749 RESPIRATORY TRACT INFECTION 4 0.0002
750 PLATELET COUNT INCREASED 2 0.0002
751 OROPHARYNGEAL PAIN 14 0.0002
752 BRADYCARDIA 8 0.0002
753 VIRAL INFECTION 5 0.0002
754 PRODUCT ADMINISTRATION ERROR 3 0.0001
755 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
756 LIMB INJURY 4 0.0001
757 PRODUCTIVE COUGH 7 0.0001
758 TREATMENT NONCOMPLIANCE 8 0.0001
759 SKIN LESION 4 0.0001
760 DRUG INTERACTION 23 0.0001
761 CARDIO-RESPIRATORY ARREST 6 0.0001
762 COORDINATION ABNORMAL 2 0.0001
763 RASH MACULAR 5 0.0001
764 LYMPHOPENIA 2 0.0001
765 GAIT DISTURBANCE 27 0.0001
766 HEPATOCELLULAR INJURY 2 0.0001
767 RETCHING 3 0.0001
768 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
769 SYNCOPE 14 0.0001
770 PARAESTHESIA 22 0.0001
771 MYELOSUPPRESSION 5 0.0001
772 MYELODYSPLASTIC SYNDROME 2 0.0001
773 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
774 INFUSION RELATED REACTION 9 0.0001
775 CONTUSION 13 0.0001
776 RASH MACULO-PAPULAR 3 0.0001
777 FATIGUE 104 0.0001
778 TREATMENT FAILURE 11 0.0001
779 ECONOMIC PROBLEM 2 0.0001
780 CEREBROVASCULAR ACCIDENT 22 0.0001
781 EXPOSURE DURING PREGNANCY 8 0.0001
782 PLASMA CELL MYELOMA 5 0.0001
783 PRODUCT USE ISSUE 24 0.0001
784 DRUG-INDUCED LIVER INJURY 4 0.0001
785 DISEASE PROGRESSION 15 0.0001
786 HEAD INJURY 4 0.0001
787 RESPIRATORY TRACT CONGESTION 2 0.0001
788 CYSTITIS 4 0.0001
789 RASH ERYTHEMATOUS 6 0.0001
790 COVID-19 22 0.0001
791 CHEST PAIN 23 0.0001
792 CONFUSIONAL STATE 20 0.0001
793 MUSCLE TIGHTNESS 2 0.0001
794 DEEP VEIN THROMBOSIS 8 0.0001
795 AGITATION 9 0.0001
796 PAIN 75 0.0001
797 DYSPEPSIA 12 0.0001
798 METASTASES TO BONE 2 0.0001
799 ACUTE CORONARY SYNDROME 1 0.0001
800 DEATH 104 0.0001
801 DECREASED APPETITE 28 0.0001
802 HEPATIC ENZYME INCREASED 8 0.0001
803 SINUSITIS 12 0.0001
804 DRUG RESISTANCE 3 0.0001
805 IRRITABILITY 7 0.0001
806 ANAPHYLACTIC SHOCK 3 0.0001
807 SKIN ULCER 3 0.0001
808 WEIGHT DECREASED 32 0.0001
809 JOINT STIFFNESS 3 0.0001
810 ANHEDONIA 3 0.0001
811 LYMPHADENOPATHY 4 0.0001
812 DRUG ERUPTION 2 0.0001
813 ISCHAEMIC STROKE 2 0.0001
814 BACK PAIN 26 0.0001
815 FEAR 3 0.0001
816 THROAT IRRITATION 5 0.0001
817 PALPITATIONS 13 0.0001
818 RASH PRURITIC 6 0.0001
819 INFECTION 16 0.0001
820 PELVIC PAIN 2 0.0001
821 BLOOD GLUCOSE ABNORMAL 2 0.0001
822 DIVERTICULITIS 3 0.0001
823 AMNESIA 7 0.0001
824 THINKING ABNORMAL 2 0.0001
825 HEPATIC CIRRHOSIS 2 0.0001
826 PHOTOPHOBIA 2 0.0001
827 MUSCULAR WEAKNESS 12 0.0001
828 BLOOD PRESSURE DECREASED 7 0.0001
829 CONVULSION 6 0.0001
830 VISUAL IMPAIRMENT 13 0.0001
831 INTERSTITIAL LUNG DISEASE 5 0.0001
832 MYOCARDIAL INFARCTION 18 0.0001
833 HAEMORRHOIDS 2 0.0001
834 BONE PAIN 6 0.0001
835 NASAL CONGESTION 6 0.0001
836 ACUTE MYOCARDIAL INFARCTION 3 0.0001
837 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
838 RENAL INJURY 3 0.0001
839 HYPERHIDROSIS 13 0.0001
840 COUGH 28 0.0001
841 DYSKINESIA 4 0.0001
842 FLUID RETENTION 5 0.0001
843 EPILEPSY 3 0.0001
844 BODY TEMPERATURE INCREASED 2 0.0001
845 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
846 PRODUCT PREPARATION ERROR 2 0.0001
847 OSTEOPOROSIS 4 0.0001
848 RHABDOMYOLYSIS 4 0.0001
849 HAEMORRHAGE 10 0.0001
850 BRONCHITIS 7 0.0001
851 OSTEOARTHRITIS 4 0.0001
852 IRRITABLE BOWEL SYNDROME 2 0.0001
853 RECTAL HAEMORRHAGE 4 0.0001
854 POOR QUALITY SLEEP 2 0.0001
855 PRURITUS GENERALISED 2 0.0001
856 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
857 ALOPECIA 18 0.0001
858 OSTEONECROSIS 3 0.0001
859 HOSPITALISATION 14 0.0001
860 FALL 30 0.0001
861 FUNGAL INFECTION 3 0.0001
862 SKIN DISORDER 3 0.0001
863 TOOTH DISORDER 2 0.0001
864 NECK PAIN 5 0.0001
865 TYPE 2 DIABETES MELLITUS 3 0.0001
866 RHEUMATOID ARTHRITIS 10 0.0001
867 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
868 BURNING SENSATION 6 0.0001
869 HEART RATE DECREASED 3 0.0001
870 BLOOD PRESSURE INCREASED 13 0.0001
871 ABDOMINAL DISCOMFORT 14 0.0001
872 BLOOD GLUCOSE DECREASED 4 0.0001
873 MYALGIA 14 0.0001
874 PRESYNCOPE 2 0.0001
875 DISCOMFORT 5 0.0001
876 ABNORMAL WEIGHT GAIN 1 0.0001
877 ABASIA 2 0.0001
878 OSTEONECROSIS OF JAW 2 0.0001
879 ANXIETY 23 0.0001
880 HEART RATE INCREASED 8 0.0001
881 EPISTAXIS 6 0.0001
882 HYPOAESTHESIA 12 0.0001
883 DYSARTHRIA 3 0.0001
884 ABDOMINAL PAIN LOWER 2 0.0001
885 HEADACHE 49 0.0001
886 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
887 RHINORRHOEA 5 0.0001
888 DIPLOPIA 2 0.0001
889 SEDATION 2 0.0001
890 PRODUCT DOSE OMISSION ISSUE 22 0.0001
891 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
892 ROAD TRAFFIC ACCIDENT 3 0.0001
893 WOUND 2 0.0001
894 EYE PAIN 4 0.0001
895 ANGINA PECTORIS 2 0.0001
896 HYPERSOMNIA 2 0.0001
897 VAGINAL HAEMORRHAGE 3 0.0001
898 RASH 30 0.0001
899 UNDERDOSE 5 0.0001
900 CHEST DISCOMFORT 7 0.0001
901 ANGIOEDEMA 3 0.0001
902 PSYCHOTIC DISORDER 2 0.0001
903 CATARACT 4 0.0001
904 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
905 THERAPY NON-RESPONDER 3 0.0001
906 LACRIMATION INCREASED 2 0.0001
907 UNEVALUABLE EVENT 5 0.0001
908 THERAPEUTIC RESPONSE DECREASED 4 0.0001
909 FEELING HOT 4 0.0001
910 ADVERSE EVENT 6 0.0001
911 PERIPHERAL SWELLING 10 0.0001
912 FEMUR FRACTURE 2 0.0001
913 DRUG INEFFECTIVE 85 0.0001
914 ACUTE MYELOID LEUKAEMIA 1 0.0001
915 BONE DENSITY DECREASED 2 0.0001
916 COMA 3 0.0001
917 WEIGHT INCREASED 14 0.0001
918 MOVEMENT DISORDER 2 0.0001
919 DIZZINESS 31 0.0001
920 NIGHT SWEATS 2 0.0001
921 HYPOGLYCAEMIA 3 0.0001
922 PAIN IN EXTREMITY 18 0.0001
923 IMPAIRED HEALING 2 0.0001
924 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
925 VISUAL ACUITY REDUCED 2 0.0001
926 DRY EYE 3 0.0001
927 GAIT INABILITY 2 0.0001
928 SKIN EXFOLIATION 5 0.0001
929 GASTRIC DISORDER 2 0.0001
930 BALANCE DISORDER 5 0.0001
931 DEPRESSION 13 0.0001
932 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
933 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
934 ADVERSE DRUG REACTION 5 0.0001
935 LOSS OF CONSCIOUSNESS 7 0.0001
936 MUSCLE SPASMS 10 0.0001
937 MEDICATION ERROR 3 0.0001
938 DYSGEUSIA 4 0.0001
939 INFLUENZA 6 0.0001
940 BLISTER 3 0.0001
941 HOT FLUSH 4 0.0001
942 ARTHRALGIA 22 0.0001
943 FLATULENCE 3 0.0001
944 MALAISE 23 0.0001
945 HERPES ZOSTER 3 0.0001
946 EYE IRRITATION 3 0.0001
947 PRURITUS 20 0.0001
948 DYSPHONIA 3 0.0001
949 SUICIDE ATTEMPT 3 0.0000
950 POLLAKIURIA 2 0.0000
951 HYPOACUSIS 2 0.0000
952 OVERDOSE 10 0.0000
953 DEVICE LEAKAGE 2 0.0000
954 MENTAL DISORDER 2 0.0000
955 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
956 TINNITUS 2 0.0000
957 NASOPHARYNGITIS 8 0.0000
958 CARDIAC DISORDER 4 0.0000
959 INJURY 3 0.0000
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
961 OCULAR HYPERAEMIA 2 0.0000
962 DISEASE RECURRENCE 2 0.0000
963 HALLUCINATION 3 0.0000
964 INFLAMMATION 2 0.0000
965 NO ADVERSE EVENT 7 0.0000
966 SPEECH DISORDER 2 0.0000
967 ARTHRITIS 3 0.0000
968 FEELING ABNORMAL 9 0.0000
969 INSOMNIA 10 0.0000
970 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
971 VISION BLURRED 5 0.0000
972 MEMORY IMPAIRMENT 5 0.0000
973 COMPLETED SUICIDE 3 0.0000
974 INCORRECT DOSE ADMINISTERED 8 0.0000
975 SURGERY 2 0.0000
976 ERYTHEMA 7 0.0000
977 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
978 EMOTIONAL DISTRESS 4 0.0000
979 HYPERSENSITIVITY 6 0.0000
980 INTENTIONAL OVERDOSE 2 0.0000
981 SWELLING FACE 2 0.0000
982 PRODUCT DOSE OMISSION 2 0.0000
983 DRY SKIN 4 0.0000
984 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
985 ACCIDENTAL OVERDOSE 1 0.0000
986 PROSTATE CANCER 2 0.0000
987 DRUG ABUSE 2 0.0000
988 URTICARIA 4 0.0000
989 PSORIASIS 3 0.0000
990 PRODUCT QUALITY ISSUE 3 0.0000
991 BREAST CANCER 2 0.0000
992 FLUSHING 2 0.0000
993 ILLNESS 2 0.0000
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
995 ACNE 1 0.0000